Sudheer Kumar Vuyyuru

Our recent study on ASUC. Colectomy at Discharge-8% 1 yr-13.5% 3yr -16.1% 5yr- 17.4% Steroid responders and non-responders have similar outcomes. Day-3 Oxford criteria remain relevant in post biologic era @vipuljairath @virgisolitano academic.oup.com/ecco-jcc/advan…

Development and external validation of an endoscopic and histologic pouchitis assessment tool: the Atlantic Pouchitis Index Congrats to ⁦@RocioSedanoMD⁩ for leading this over the last 5 years and to all collaborators for their guidance and input. pubmed.ncbi.nlm.nih.gov/40675404/

@dr_singh_gastro @APTJournal Congratulations @dr_singh_gastro

What's the best way to maintain remission after IV steroids in ASUC? Our latest study compares Azathioprine (AZA) vs Tofacitinib (TOFA) in steroid-responsive ASUC. Published in @APTJournal 🔗 doi.org/10.1111/apt.70… 👇

Available online from today, the latest @BritSocGastro IBD guidelines. Thank you to all who contributed. gut.bmj.com/content/74/Sup…

@BritSocGastro IBD Guidelines 2025 - out now! : gut.bmj.com/content/74/Sup…

An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease. Much needed effort to standardize the approach to steroids in trials lead by ⁦@ChrisMa_YYC⁩ with global contributions! pubmed.ncbi.nlm.nih.gov/40446946/

Department of Medicine Residents Research Day. This year we had 95 abstracts from our trainees sharing their research from basic science, clinical research, QI and education research. Thanks to all of our trainees and faculty who made this a success @SchulichMedDent @WesternU

Excited to share that I’ve completed the IBUS training in intestinal ultrasound for IBD. Grateful to learn this new skill #IBUS Thanks to Dr.Siwar Albashir, Dr.Prowse at McMasters and @GordonMoranIBD @drgauraang @vipuljairath for encouragement and support @BowelUltrasound

Check out our recent comprehensive review on IL23 inhibitors in CD @vipuljairath @SpringerNature #IL23p19, #Crohn’s disease #biologics pubmed.ncbi.nlm.nih.gov/40323342/

📢 Join us on Tuesday, May 20th at 1:00 PM CET for another exclusive IBUS SciCom Webinar on "Standardized IUS Scoring in IBD" with Dr. Gabriele Dragoni, Dr. Chris Ma and Dr. Christoph Teichert 👉 Visit the IBUS website for more details and to register: ibus-group.org/event/webinar-…

@PDulaiMD @AGA_CGH

Glad to share our recently published systematic review and meta analysis on ASUC. @vipuljairath @alimentiv pubmed.ncbi.nlm.nih.gov/40339949/

💥Our latest on how AI is revolutionizing IBD CTs!💥 AI is boosting patient recruitment, trial efficiency, personalized ttm, endpoint assessment & tackling key ethical & reg challenges👇@vipuljairath @virgisolitano @chrisma_yyc @olga_nardone @IBDologist journals.sagepub.com/doi/10.1177/17…

@vipuljairath @virgisolitano @SchulichMedDent @LHSCCanada All the best @virgisolitano. Im so grateful to have a brilliant and hardworking friend like you. Will miss you at Western.

Last endoscopy list after a two year clinical research fellowship. A true star and brilliant person all round. We will miss you ⁦⁦@virgisolitano⁩ and can’t wait to support and celebrate your next chapters in life. ⁦@SchulichMedDent⁩ ⁦@LHSCCanada⁩

@dreileenc @getgutsycanada @AleixoMMuise @vipuljairath @annegri50789035 @ericbenchimol @brianf @FrostKarenLee @WesternU @SchulichMedDent @LHSCCanada Congratulations @dreileenc 🙌

Thank you @getgutsycanada I am so honoured to receive this prestigious award!☺️ Very grateful for fantastic mentors to guide me in my pIBD research journey @AleixoMMuise @vipuljairath @annegri50789035 @ericbenchimol @BrianF @FrostKarenLee @WesternU @SchulichMedDent @LHSCCanada

"Unable To Accept...": Leading Industrialists Remember #RatanTata 🖇️ ndtv.com/india-news/rat…

Tough cases in IBD - spirited discussion from our expert panel. @IBDMD @SeowCynthia @MatthieuAllez @vipuljairath @guthealthmd @ScopeCanMD

How often during a colonoscopy in a patient w #CD could we have missed lesions that would have led to a change in therapy? I’ve wondered about this many times @virgisolitano addresses it in her 📄 🔍 22.3% had lesions proximal to the TI 🔍 24.5% SB skip lesions in the ileum 🔍 10.4% had strictures @vipuljairath @IBDJournals #google_vignette" target="_blank" rel="nofollow noopener">academic.oup.com/ibdjournal/adv…

@alat_tech M no

#Alat is embarking on an ambitious path to becoming a global leader in robotics and industrial automation. Our robotics facilities will be built with efficiency and driven by a commitment to a sustainable planet.